Search

Your search keyword '"Kamiunten, Ayako"' showing total 176 results

Search Constraints

Start Over You searched for: Author "Kamiunten, Ayako" Remove constraint Author: "Kamiunten, Ayako"
176 results on '"Kamiunten, Ayako"'

Search Results

1. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers

2. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma

3. Whole-genome landscape of adult T-cell leukemia/lymphoma

6. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia

7. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

8. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

9. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

11. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan

12. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma

13. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

14. Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

15. Preclinical Translational Research Suggests a Clinical Trial Strategy for a Novel MALT1 Inhibitor ONO-7018/CTX-177 Against Malignant Lymphomas

16. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma

17. The effect of CARD11 mutation and HBZ expression accelerated lymphoproliferative diseases and formed the pathological basis for adult T-cell leukemia/lymphoma

18. Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

19. Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation

20. Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan

21. CD3 and EBER double positive cells in bone marrow are a diagnostic aid for EBV-positive T-cell lymphoproliferative disorders of childhood

22. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan

23. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma

24. Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma

25. Preclinical Evaluation of a Novel MALT1 Inhibitor CTX-177 for Relapse/Refractory Lymphomas

28. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice

29. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms

30. TP53 and PTEN Mutations Were Shared in Concurrent Germ Cell Tumor and Acute Megakaryoblastic Leukemia

31. Depletion of Neoplastic CD11b Positive Cells in Jak2V617F Mutant Mice Reduced Fibrocytes in Bone Marrow and Improved Myelofibrosis

32. The Role of Calreticulin in Normal Hematopoiesis and Neoplastic Hematopoiesis of Myeloproliferative Neoplasms

33. Haploinsufficiency of CALR Confers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the Calr Mutation

34. TET2 Mutation Associated with Organ Infiltrations in ATLL

35. Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma.

37. Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice

38. Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations

39. TET2 mutation in diffuse large B-cell lymphoma

40. Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice

41. Mogamulizumab for ATLL in Clinical Practice

42. TYK2 Is Essential for IFNα-Induced Resolution of MPN Features in a Murine Jak2V617F PMF Model

43. Clinical Outcomes of Tucidinostat Therapy for Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma (ATL) in Clinical Practice

45. Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms

46. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma

47. Nasopharyngeal Carcinoma with Bone Marrow Metastasis: Positive Response to Weekly Paclitaxel Chemotherapy

Catalog

Books, media, physical & digital resources